Topical microbicides in HIV prevention: state of the promise
HIV topical microbicides are products with anti-HIV activity, generally incorporating a direct-
acting antiretroviral agent, that when applied to the vagina or rectum have the potential to …
acting antiretroviral agent, that when applied to the vagina or rectum have the potential to …
Client-centered adherence counseling with adherence measurement feedback to support use of the dapivirine ring in MTN-025 (The HOPE Study)
Fostering adherence and open communication about adherence challenges is key to
harnessing the potential of biomedical HIV prevention products. We describe the counseling …
harnessing the potential of biomedical HIV prevention products. We describe the counseling …
Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to …
AR Bardon, J Dorward, Y Sookrajh, F Sayed… - BMJ open, 2021 - bmjopen.bmj.com
Introduction Substantial improvements in viral suppression among people living with HIV
(PLHIV) are needed to end the HIV epidemic, requiring extensive scale-up of low-cost HIV …
(PLHIV) are needed to end the HIV epidemic, requiring extensive scale-up of low-cost HIV …
An open-label pharmacokinetic and pharmacodynamic assessment of tenofovir gel and oral emtricitabine/tenofovir disoproxil fumarate
IM McGowan, RP Kunjara Na Ayudhya… - AIDS research and …, 2022 - liebertpub.com
The Microbicide Trials Network-017 study was undertaken to characterize the safety,
acceptability, pharmacokinetic (PK), and pharmacodynamic profile of the reduced-glycerin …
acceptability, pharmacokinetic (PK), and pharmacodynamic profile of the reduced-glycerin …
Low disclosure of PrEP nonadherence and HIV-risk behaviors associated with poor HIV PrEP adherence in the HPTN 067/ADAPT study
Objective: We evaluated the relationship between 2 types of social relationships, ie,(1)
external support for use of HIV pre-exposure prophylaxis (PrEP) and related study supplies …
external support for use of HIV pre-exposure prophylaxis (PrEP) and related study supplies …
[HTML][HTML] Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an …
AR Bardon, JM Simoni, LM Layman, JD Stekler… - AIDS Research and …, 2020 - Springer
Background Real-time, objective measures of adherence to antiretroviral therapy (ART) and
pre-exposure prophylaxis (PrEP) are needed to better assess adherence levels and to …
pre-exposure prophylaxis (PrEP) are needed to better assess adherence levels and to …
Women's experience receiving drug feedback and adherence counseling in MTN-025/HOPE-an HIV Prevention open-label trial of the Dapivirine Vaginal Ring
Abstract In the Phase IIIB MTN-025/HOPE open label extension trial, participants were
offered the dapivirine vaginal ring as HIV prophylaxis, and those who accepted the ring …
offered the dapivirine vaginal ring as HIV prophylaxis, and those who accepted the ring …
[HTML][HTML] Methods, system errors, and demographic differences in participant errors using daily text message-based short message service computer-assisted self …
Background Assessment of sexual risk behavior is crucial to HIV prevention trials. Currently,
there are no biomarkers or objective measures to detect and characterize sexual risk …
there are no biomarkers or objective measures to detect and characterize sexual risk …
Sharing objective measures of adherence to a vaginal microbicide promotes candor about actual use and bolsters motivation to prevent HIV
Discrepancies between self-reported and actual adherence to biomedical HIV interventions
is common and in clinical trials can compromise the integrity of findings. One solution is to …
is common and in clinical trials can compromise the integrity of findings. One solution is to …
[HTML][HTML] Protocol: Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load …
AR Bardon, J Dorward, Y Sookrajh, F Sayed… - BMJ Open, 2021 - ncbi.nlm.nih.gov
Introduction Substantial improvements in viral suppression among people living with HIV
(PLHIV) are needed to end the HIV epidemic, requiring extensive scaleup of low-cost HIV …
(PLHIV) are needed to end the HIV epidemic, requiring extensive scaleup of low-cost HIV …